PACRITINIB for Marrow hyperplasia: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 17 adverse event reports in the FDA FAERS database where PACRITINIB was used for Marrow hyperplasia.
Most Reported Side Effects for PACRITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Diarrhoea | 536 | 20.9% | 13 | 64 |
| Off label use | 459 | 17.9% | 33 | 56 |
| Fatigue | 320 | 12.5% | 9 | 40 |
| Product dose omission issue | 279 | 10.9% | 6 | 60 |
| Death | 261 | 10.2% | 260 | 23 |
| Nausea | 246 | 9.6% | 8 | 36 |
| Platelet count decreased | 237 | 9.3% | 4 | 42 |
| Haemoglobin decreased | 171 | 6.7% | 5 | 43 |
| Asthenia | 119 | 4.6% | 5 | 22 |
| Drug ineffective | 98 | 3.8% | 2 | 9 |
| Dizziness | 96 | 3.8% | 4 | 12 |
| Splenomegaly | 84 | 3.3% | 2 | 11 |
| Transfusion | 83 | 3.2% | 1 | 23 |
| Constipation | 75 | 2.9% | 2 | 9 |
| Dyspnoea | 75 | 2.9% | 3 | 23 |
Other Indications for PACRITINIB
Myelofibrosis (1,586)
Myeloproliferative neoplasm (365)
Product used for unknown indication (154)
Myelodysplastic syndrome (112)
Polycythaemia vera (112)
Essential thrombocythaemia (66)
Acute myeloid leukaemia (21)
Thrombocytopenia (21)
Chronic myelomonocytic leukaemia (13)
Immune thrombocytopenia (12)